Shen et al. demonstrated that GLUT5, in collaboration with KHK, promotes proliferation and chemotherapy resistance in CRC by facilitating fructose metabolism; accordingly, restricting fructose availability or inhibiting this metabolic pathway significantly suppresses tumor growth and enhances chemotherapy sensitivity 32. This evidence concerns the gene SLC2A5 and colorectal carcinoma.